Atorvastatin Delays Murine Platelet Activation In Vivo Even in the Absence of Endothelial NO Synthase
Author(s) -
Ran Ni,
Tal Peleg,
Peter L. Gross
Publication year - 2012
Publication title -
arteriosclerosis thrombosis and vascular biology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.007
H-Index - 270
eISSN - 1524-4636
pISSN - 1079-5642
DOI - 10.1161/atvbaha.112.300090
Subject(s) - enos , atorvastatin , platelet activation , thrombin , in vivo , chemistry , platelet , agonist , endothelial activation , pharmacology , medicine , endocrinology , receptor , endothelium , biology , nitric oxide synthase , nitric oxide , microbiology and biotechnology
Statins decrease mortality in patients with vascular disorders, and evidence for the pleiotropic effects of statins is accumulating. Statins enhance endothelial NO synthase (eNOS) expression, thereby attenuating platelet activation and thrombus formation. Our goal was to determine whether statins have eNOS-independent effects on platelet activation.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom